Global Thrombectomy Devices Market 2014 to 2022Posted by Ravi Parmar on May 4th, 2017 Report Description: The Global thrombectomy devices market is estimated to garner revenue of ,389 million by 2022, from 2 million in 2016, at an CAGR of 5.9% from 2016 to 2022. Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. These are carefully designed to minimize damage to the vessel wall during a procedure, with the minimum blood loss. They are available in different sizes and diameters, and depending on the affected area, the required catheter is chosen. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions. Browse Full Report Visit - http://www.acutemarketreports.com/report/thrombectomy-devices-market This is attributed by the increase in the incidence of chronic diseases due to the sedentary lifestyle, and unhealthy living conditions and habits in the current generation. Also, the rise in the geriatric population has led to increase in the incidence of cardiovascular diseases, which will be one of the growth factors of the thrombectomy devices market. The growth in demand for minimally invasive procedures, and better healthcare infrastructure along with the increase in the competition, has led to technological advancements and innovations. These factors will further drive the market of thrombectomy devices. However, lack of trained professionals and complicated use of these devices restrict the market growth. In addition, deep vein thrombosis and pulmonary embolism sometimes remain underdiagnosed and can lead to serious health conditions, which can only be avoided by escaping the sedentary lifestyle and creating awareness among all. Browse All Reports of This Category - http://www.acutemarketreports.com/category/medical-equipments-market Key players have adopted product launch and mergers & acquisitions as their key development strategies. For instance, on September 2015, Medtronic acquired Lazarus Effect to strengthen its market of clot removal devices effective during ischemic stroke. Also, market leader Boston Scientific received FDA approval and CE mark for its thrombectomy product line called AngioJet ZelanteDVT Thrombectomy Catheter on November 2015. This has helped Boston Scientific to continue to be the leading innovator for peripheral vascular disease in the industry, and expanded their product portfolio and sales force across various geographies. The key players profiled in this report include Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation, AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, and Vascular Solutions, Inc. Mechanical thrombectomy devices was the highest revenue-generating segment in 2015 followed by aspiration and rheolytic thrombectomy devices. This is attributed by the fact that mechanical thrombectomy has the highest usage amongst the three technologies available. Also, they are able to deliver better results especially in the ischemic stroke cases. However, market for rheolytic thrombectomy devices will grow faster than mechanical thrombectomy devices owing to the fact that the technological advancements are adopted for more efficient results. Also, the growth in incidences of peripheral and coronary diseases will drive the market for rheolytic thrombectomy devices. Browse For Complete Report Here : Thrombectomy Devices Market by Thrombectomy Devices Technology 2022 The Indian thrombectomy devices market is projected to grow at a CAGR of 11.4% during forecast period. This growth can be attributed to the development of R&D, increased number of aged population, and high prevalence of PAD. Penumbra System launched its first mechanical thrombectomy device approved by Drug Control General of India to treat acute ischemic stroke. The devices launched in India are Trevo Stent Retriever, product by Stryker and Solitaire Stent Retriever System by Medtronic used for revascularization. Teleflex Incorporated present as Teleflex Medical India, Medtronic and Stryker are key vendors of thrombectomy device market in India. THROMBECTOMY DEVICES MARKET KEY BENEFITS FOR STAKEHOLDERS The Global thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market. Chapter: 1 INTRODUCTION Chapter: 2 EXECUTIVE SUMMARY 2.1 CXO perspective Chapter: 3 MARKET OVERVIEW Latest Reports : http://www.acutemarketreports.com/report/commercial-aircraft-market-report http://www.acutemarketreports.com/report/aerial-imaging-market-report http://www.acutemarketreports.com/report/transplant-diagnostics-market-report About - Acute Market Reports : Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online. Like it? Share it! More by this author |